000 01361 a2200397 4500
005 20250517153010.0
264 0 _c20180402
008 201804s 0 0 eng d
022 _a1502-7732
024 7 _a10.1080/03009742.2017.1290822
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBerthold, E
245 0 0 _aTumour necrosis factor-α/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis.
_h[electronic resource]
260 _bScandinavian journal of rheumatology
_cJan 2018
300 _a22-26 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAntirheumatic Agents
_xtherapeutic use
650 0 4 _aArthritis, Rheumatoid
_xblood
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aEtanercept
_xblood
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aTumor Necrosis Factor-alpha
_xblood
700 1 _aMånsson, B
700 1 _aGullstrand, B
700 1 _aGeborek, P
700 1 _aSaxne, T
700 1 _aBengtsson, A A
700 1 _aKahn, R
773 0 _tScandinavian journal of rheumatology
_gvol. 47
_gno. 1
_gp. 22-26
856 4 0 _uhttps://doi.org/10.1080/03009742.2017.1290822
_zAvailable from publisher's website
999 _c27154755
_d27154755